| Literature DB >> 28458992 |
Mehmet Demır1, Mustafa Cicek1, Nadire Eser2, Atila Yoldaş1, Turgay Sısman3.
Abstract
The acute phase effects of toluene on the brain have been investigated in this study using rabbit brain via histopathological, immunohistochemical, and biochemical methods. A total of 20 male rabbits were used as control and experimental groups. Moreover, nerve growth factor (NGF), tumor necrosis factor-alpha (TNF-alpha), dopamine (DA), and glial fibrillary acidic protein (GFAP) tests were performed in order to designate the severity of the biochemical damage. In the biochemical evaluation of the prefrontal cortex, hippocampus, hypothalamus, substantia nigra, and entorhinal cortex, the TNF-alpha levels in the brain were found to be significantly higher than in the control group. Levels of dopamine, secreted from the substantia nigra, nerve growth factor (NGF) developed from the hippocampal neurons, and GFAP, secreted from astrocyte cells, were detected to be significantly lower in the toluene-administration group than in the control group (p < 0.05). In addition, areas of focal vacuolar degeneration (abscess formation), gliosis, and perivascular demyelination, many pyknotic cells and necrosis were observed. In the toluene-administration group compared to the control group, distinct excessive expansions of the blood vessels and severe degeneration in the structure of cells and also dispersed cell borders were observed. Furthermore, abnormal malformations of the nuclei structure of the oligodendrocyte cells were seen. Bodies of the sequential neurons of the hippocampus in the toluene-administration group were distinctly structurally damaged compared to the control group. In addition, cytoplasm of the cortex cell showed serious immune reactivity in the experimental group.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28458992 PMCID: PMC5385213 DOI: 10.1155/2017/2805370
Source DB: PubMed Journal: Anal Cell Pathol (Amst) ISSN: 2210-7177 Impact factor: 2.916
TNF-alpha, dopamine, NGF, and GFAP serum levels.
| Groups |
|
| ||
|---|---|---|---|---|
| Control | Toluene receiving | |||
| Mean ± SD | Mean ± SD | |||
| TNF-alpha | 323,02 ± 3.72856 | 582.24 ± 12.41 | 63.298 | 0.001 |
| Dopamine | 6.94 ± 1.10099 | 4.42 ± 0.68 | 6.134 | 0.001 |
| NGF | 47.12 ± 3.07560 | 23.09 ± 4.59 | 13.745 | 0.001 |
| GFAP | 12.22 ± 1.26635 | 8.06 ± 1.89 | 5.766 | 0.001 |
Significant differences between the control and the toluene receiving groups. The level of significance was set as α = 0,05; independent sample t-test.
Figure 1H&E stained. (a) Control group, entorhinal cortex, H&E (×20). (b) Toluene-administered group, entorhinal cortex, H&E (×20). (c) Control group, hippocampal area, H&E (×40). (d) Toluene-receiving group, hippocampal area, H&E (×40). (e) Control group, prefrontal cortex, H&E (×40). (f) Toluene-administered group, prefrontal cortex, H&E (×40).
Figure 2Immunohistochemical staining. (a) Control group, Bax immunoreactivity (×40). (b) Control group, C3 immunoreactivity (×40). (c) Toluene-administered group, Bax immunoreactivity (×40). (d) Toluene-administered group, C3 immunoreactivity (×40).